Dr. Sven K. Weber (M)
Vorstandsvorsitzender
As CEO of BRAIN Biotech AG, I reaffirm our commitment to the Women’s Empowerment Principles. Equal opportunities to contribute, develop and lead make our teams stronger and our business more resilient. Building on the work already started, we will continue to embed the WEPs as part of our ESG strategy and track our progress
General Information
WEPs signatory since 18 February 2026
Public
201-500 employees
Baseline
Between 30% and 50% women employees.
Less than 30% women at management level.
Between 30% and 50% women on boards/executive team/partners.
Industry
Biotechnology
Location
Germany
Europe and Central Asia
Also operating and will implement WEPs in the following countries and regions:
Other Countries
Netherlands
United Kingdom of Great Britain and Northern Ireland
United States of America
Progress - 2026
Percentage of women and men employees
- 45 - 50%
- 45 - 50%
Percentage of women and men in senior management positions
- 26 - 30%
- 71 - 75%
Percentage of women and men on the company board
- 36 - 40%
- 61 - 65%
Has a confidential grievance, resolution, reporting and non-retaliation mechanism and procedure to respond to incidents of violence and harassment
Last updated on: 28 October 2026